Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers
Clinical trial NCT05267912 · RECRUITING
Trial details
- NCT number
- NCT05267912
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-19
- Primary completion
- 2028-01-18
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.